Role of ceftriaxone in sexually transmitted diseases.

Abstract	Ceftriaxone is a third-generation cephalosporin with antibacterial and pharmacokinetic characteristics that make it an excellent choice for the treatment of gonococcal infection and chancroid. Adverse effects are unusual. Clinical efficacy in all reported studies has been excellent. Additional studies are required for further elucidation of the role of ceftriaxone in the treatment of pelvic inflammatory disease and syphilis. Chlamydial infections are not altered by ceftriaxone, and additional treatment is necessary if Chlamydia is present concurrently with Neisseria gonorrhoeae.
Authors	N Le Saux, A R Ronald
Journal	Reviews of infectious diseases (Rev Infect Dis) 1989 Mar-Apr Vol. 11 Issue 2 Pg. 299-309 ISSN: 0162-0886 [Print] United States
PMID	2649963 (Publication Type: Journal Article, Review)
Chemical References	Ceftriaxone
Topics	Ceftriaxone (therapeutic use) Chancroid (drug therapy) Chlamydia Infections (complications, drug therapy) Chlamydia trachomatis Female Gonorrhea (complications, drug therapy) Humans Male Sexually Transmitted Diseases (drug therapy) Syphilis (complications, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!